Latest news with #GlobalVirusNetwork
India Today
09-06-2025
- Health
- India Today
Global Virus Network issues guidance on new Covid-19 variant, vaccine protection
The newly identified Covid-19 variant, named NB.1.8.1, is spreading rapidly across parts of Asia including India and other regions such as the United the variant has sparked concern due to its rising numbers, global health experts are urging caution, not Global Virus Network (GVN) - an international coalition of top virologists and research centres - which is closely tracking the situation, says there is no current evidence that NB.1.8.1 causes more severe illness than earlier However, its growing presence has led the World Health Organisation (WHO) to list it as a 'Variant Under Monitoring.'The variant, a sub-lineage of the Omicron family, was first detected in January 2025 and has now been found in 22 of May 18, 2025, NB.1.8.1 accounted for 10.7% of global Covid-19 virus samples submitted to the international database GISAID, global science initiative and primary source for freely sharing genomic data of viruses, especially influenza viruses. There is no current evidence that NB.1.8.1 causes more severe illness than earlier variants. () This is a sharp rise from just 2.5% four weeks earlier. In India, active Covid-19 cases have climbed to 6,491 (as of June 9), with more than 500 new infections reported in the past 24 such as Delhi, Kerala, Gujarat, Uttar Pradesh, and West Bengal are reporting steady increases in countries are also seeing a rise. In Taiwan, hospital visits due to Covid-19 symptoms rose by 78% in one week, with nearly 6,000 people seeking care between April 27 and May the United States, more than a dozen cases of NB.1.8.1 have been reported, initially detected through airport screenings in California, Washington, Virginia, and New York. The variant has since been found in Ohio, Rhode Island, and the rise in infections, experts say the pattern remains consistent with seasonal surges, and vaccines continue to provide strong protection against serious WE KNOW ABOUT NB.1.8.1NB.1.8.1 shares many characteristics with previous Omicron variants, including mutations in the spike protein that help the virus spread more easily. NB.1.8.1 shares many characteristics with previous Omicron variants, including mutations in the spike protein that help the virus spread more easily. () But early studies show it does not lead to more severe disease or significantly escape the protection offered by vaccines or past infections may happen, especially in people with waning immunity or those who are unvaccinated. But vaccines remain highly effective in preventing hospitalisation and death," the GVN treatments like Paxlovid (nirmatrelvir/ritonavir) and remdesivir also continue to work well against this and other Omicron REMAINS KEYIn its latest guidelines, the coalition emphasised the importance of staying up to date with Covid-19 vaccinations, especially as the virus are the GVN's updated vaccine recommendations:Adults over 65 and those with underlying health issues should get an updated booster tailored to current aged 6 months and older is encouraged to remain current with vaccinations, particularly before the respiratory illness seasons in autumn and and teenagers should receive age-appropriate vaccine doses if they haven't been vaccinated in the past year. This helps prevent complications like hospitalisation or MIS-C (a serious inflammatory condition in children).Pregnant individuals are strongly advised to get vaccinated. According to GVN, studies show that Covid-19 vaccination during pregnancy reduces hospitalisation risk in infants by 61% and helps protect the newborn for up to six months. It also lowers the risks of preterm birth and other who haven't received a Covid-19 booster in the past year should speak with their doctor about timing and eligibility. Co-administering Covid-19 and flu vaccines is safe and recommended when needed. Side effects from both vaccines remain CAUSE FOR ALARMHealth authorities are clear: the emergence of new variants like NB.1.8.1 is expected and does not mean we are entering a new emergency.'This is not a reason to panic, but a moment to prepare,' the GVN said. The key lies in continued vigilance, accurate public information, and strong global and WHO are encouraging nations to maintain timely virus tracking and share data to support early detection and NB.1.8.1 is spreading, the tools we have, vaccines, treatments, and knowledge, are still YOU CAN DOFor the public, experts recommend continuing to follow good health practices:advertisementStay up to date with Covid-19 a mask in crowded indoor spaces if cases are rising in your good hand home if you feel sick and get tested if symptoms your doctor about booster shots or antiviral treatment if you are at higher Covid-19 continues to evolve, health agencies worldwide are shifting from emergency response to long-term management. That includes regular vaccination updates, like with influenza, and clear communication to avoid misinformation and panic."Scientific collaboration, accurate public communication, and continued investment in prevention tools will remain critical in navigating the evolving Covid-19 landscape," said InMust Watch
Morocco World
09-06-2025
- Health
- Morocco World
New Covid-19 Variant Rapidly Spreads Across Continents
Rabat — A newly identified COVID-19 variant known as NB.1.8.1 is spreading rapidly across multiple parts of the world, raising concerns among global health experts. The variant, which belongs to the Omicron family, was first detected in January 2025 and has since reached countries including the United States, United Kingdom, Australia, China, India, Maldives and Egypt. According to British news reports, doctors in Ireland have reported that NB.1.8.1 is causing unusual symptoms compared to previous strains. In addition to common signs like sore throat and fatigue, patients are also experiencing gastrointestinal problems such as nausea, diarrhea, vomiting, heartburn, bloating, and abdominal pain. Irish health authorities are urging anyone with these symptoms to stay home and avoid contact with others until 48 hours after symptoms resolve, warning that the illness could be mistaken for seasonal colds or stomach bugs. The World Health Organization (WHO) has officially labeled it a 'Variant Under Monitoring,' meaning it is spreading fast enough to warrant attention, but not enough to be classified as a major threat. The Global Virus Network, a leading coalition of virologists and medical researchers, says there is no current evidence that this variant causes more severe illness than previous ones. Like earlier Omicron sub-variants, NB.1.8.1 includes genetic changes that help it spread more easily, but vaccines—especially updated booster doses—continue to protect from the most severe effects. While breakthrough infections can still happen, especially among people who are unvaccinated or have not received a recent booster, vaccinated individuals are reportedly far less likely to suffer serious illness. Health experts stress that the main benefit of COVID-19 vaccination is not avoiding infection altogether, but avoiding severe outcomes like hospitalization, long-term complications, or death. Global spread Recent data from the WHO shows that NB.18.1 has been detected in at least 22 countries. Between late April and early May, the variant grew from just 2.5 percent to over 10 percent of global samples. In India, over 4,300 active COVID-19 cases have been reported as of early June, with nearly 300 new infections in a single day. Several states, including Delhi and Kerala, have seen consistent rises in cases. In Taiwan, hospital visits linked to COVID-19 symptoms rose nearly 80 percent in one week at the end of April. In the US, the variant has been identified in multiple states, first through airport screening and later in community cases, including in Washington, Ohio, and Hawaii. The US continues to report roughly 300 COVID-related deaths each week. In response to this growing spread, the Global Virus Network is urging eligible individuals to get vaccinated or boosted. Adults over 65, people with chronic health conditions, and pregnant individuals are strongly encouraged to stay up to date on their COVID-19 shots. Pediatric vaccination is also being emphasized, particularly for children who have not received an updated dose in the past year. Vaccination during pregnancy, experts note, offers significant protection to both mother and baby, lowering the risk of hospitalization for infants and reducing complications related to COVID-19 infection during pregnancy. Although the rise of NB.1.8.1 has not triggered emergency action, experts say it is a clear reminder of the need for strong global surveillance, continued scientific cooperation, and public awareness. The emergence of new variants is expected, they stress, and should be met with preparation rather than panic. This moment, they say, is not a crisis—but a chance to stay ahead.
Free Malaysia Today
04-06-2025
- Business
- Free Malaysia Today
Trump's WHO withdrawal could cost the US dearly
While the Covid-19 pandemic is firmly in the past for many Americans, US households continue to bear the costs of infectious-disease outbreaks. A few months ago, the price of eggs in the US soared to a record high, largely owing to the spread of H5N1 bird flu. Since March 2024, the virus has ravaged US chicken farms, leading to tens of millions of poultry deaths from infection or culling. More ominously, at least 70 human cases of bird flu have been identified in the US, with one death reported in Louisiana. In a recent report about enhancing the response to H5N1 in America and globally, the Global Virus Network, a consortium of the world's top virologists, warned of 'the terrible consequences of underreacting to current threats'. But while bird flu poses the most immediate risk to Americans, it is by no means the only one. Virulent infectious-disease outbreaks in other countries, such as mpox in the Democratic Republic of the Congo, Ebola in Uganda, Marburg in Tanzania, and multi-country outbreaks of cholera, do not respect borders, and thus are a threat to people everywhere – including in the US. Without the efforts of the World Health Organization (WHO) to contain these outbreaks, the risk of wider transmission would be much greater. This underscores the need for a global agency like WHO to supervise cross-border cooperation – and the shortsightedness of President Donald Trump's decision to withdraw the US from the organisation. Despite being the world's richest and most powerful country, America is not immune to another Covid-style calamity, and abandoning multilateralism and neglecting pandemic preparedness (such as the stockpiling of treatments and vaccines) will make it all the more vulnerable. One might think that the deadly spread of Covid-19, prolonged by the emergence of new virus strains, would convince policymakers to strengthen the world's public-health architecture – especially as experts warn that future pandemics could be even worse. But with other leaders indicating that they may follow Trump's example and leave WHO, the resources for pandemic prevention and control could dwindle to the point that global outbreaks become more frequent and difficult to overcome. If Trump follows through with the move, his administration will become increasingly isolated and impotent. American officials, including at US military installations abroad, will lose access to WHO-led and -facilitated global networks that collect and share information about infectious-disease threats and respond to outbreaks. Moreover, the US government will have no say in developing new solutions (which will almost invariably be less effective) for controlling the spread of diseases across borders – including its own. Trump has suggested that he may change his mind, presumably if the grievances set out in his executive order to withdraw the US from the organisation are addressed. This implies that WHO should apply pressure on China to identify the pandemic's origins. WHO director-general Tedros Adhanom Ghebreyesus, for his part, has refused to accept the Chinese government's prevarications. If Trump can propose a way to determine the cause of Covid-19, I am sure that WHO's leadership would gladly hear it. Trump's second condition is that WHO undertakes reforms and uses its resources more effectively at the local level, with a greater focus on stopping the spread of infectious diseases. This is a demand that can and should be met. To that end, Tedros has already promised more targeted use of funds and implemented other measures to transform the organisation. In addition, under Tedros, WHO has transformed the way it raises funds. Its member states have sharply increased their annual contributions, and it has diversified its donor base to share the funding load more widely. This is all part of WHO's drive to be more sustainably financed, a plan launched as part of Tedros's effort to transform the organisation's operations after he took office in 2017. Back then, he and member states assessed that the departure of a major donor could leave WHO's programmes and independence vulnerable to funding shocks. Who knew it would be the US. But, had those changes not been made, we can only imagine how much more challenging WHO's current financial situation would be. The Trump administration should welcome these changes, not least because it benefits from having a seat at the table. If the US ultimately abandons WHO, developing evidence-based guidance and regulations for chronic-disease prevention and management will be significantly harder, undermining the administration's goal of addressing America's chronic-disease epidemic. The US will also no longer be a part of WHO's medicine prequalification process, a programme that opens a host of new markets for drug producers in a cost-effective manner. Instead, US pharmaceutical companies will be forced to sell their prequalified products to each country individually, putting them at risk of losing access to highly profitable multibillion-dollar markets. Twenty-first-century trends – including more mobility and international travel, greater urbanisation, and increasing human encroachment on nature – fuel the global spread of infectious diseases, to the detriment of everyone. US officials would be better positioned to protect their citizens if they joined – and perhaps even led – a discussion on how WHO and other global health organisations, such as Gavi, the Vaccine Alliance, and the Global Fund to Fight AIDS, Tuberculosis, and Malaria, can meet the world's needs. One such initiative, in which the US had been a strong partner until Trump took office, was to negotiate a WHO Pandemic Agreement, which was adopted by consensus by WHO member states at the World Health Assembly on May 20. This historic compact, based on the principles of equity, collaboration, and the reaffirmation of national sovereignty in public-health decision-making, will make the world safer from future pandemics. The US, bolstered by its world-class medical professionals and substantial public investment in medical research, has long exerted considerable influence on global health priorities. But withdrawing from WHO places America on the outside, unable to shape the agency's policy agenda and reforms. When the next pandemic strikes, the US will be left watching from the sidelines, as WHO and its remaining member countries manage the global response and pick up the pieces as they see fit. Gordon Brown, a former prime minister of the UK, is UN special envoy for global education and chair of Education Cannot Wait. The views expressed are those of the writer and do not necessarily reflect those of FMT.
Japan Times
02-06-2025
- Business
- Japan Times
Trump's WHO withdrawal could cost the U.S. dearly
While the COVID-19 pandemic is firmly in the past for many Americans, U.S. households continue to bear the costs of infectious-disease outbreaks. A few months ago, the price of eggs in the United States soared to a record high, largely owing to the spread of H5N1 bird flu. Since March 2024, the virus has ravaged U.S. chicken farms, leading to tens of millions of poultry deaths from infection or culling. More ominously, at least 70 human cases of bird flu have been identified in the U.S., with one death reported in Louisiana. In a recent report about enhancing the response to H5N1 in America and globally, the Global Virus Network, a consortium of the world's top virologists, warned of 'the terrible consequences of underreacting to current threats.' But while bird flu poses the most immediate risk to Americans, it is by no means the only one. Virulent infectious-disease outbreaks in other countries, such as mpox in the Democratic Republic of the Congo, Ebola in Uganda, Marburg in Tanzania and multicountry outbreaks of cholera do not respect borders and thus are a threat to people everywhere — including in the U.S. Without the efforts of the World Health Organization to contain these outbreaks, the risks of wider transmission would be much greater. This underscores the need for a global agency like the WHO to supervise cross-border cooperation — and the shortsightedness of U.S. President Donald Trump's decision to withdraw the U.S. from the organization. Despite being the world's richest and most powerful country, America is not immune to another COVID-19-style calamity and abandoning multilateralism and neglecting pandemic preparedness (such as the stockpiling of treatments and vaccines) will make it all the more vulnerable. One might think that the deadly spread of COVID-19, prolonged by the emergence of new virus strains, would convince policymakers to strengthen the world's public-health architecture — especially as experts warn that future pandemics could be even worse. But with other leaders indicating that they may follow Trump's example and leave the WHO, the resources for pandemic prevention and control could dwindle to the point that global outbreaks become more frequent and difficult to overcome. If Trump follows through with the move, his administration will become increasingly isolated and impotent. American officials, including at U.S. military installations abroad, will lose access to the WHO-led and -facilitated global networks that collect and share information about infectious-disease threats and respond to outbreaks. Moreover, the U.S. government will have no say in developing new solutions (which will almost invariably be less effective) for controlling the spread of diseases across borders — including its own. Trump has suggested that he may change his mind, presumably if the grievances set out in his executive order to withdraw the U.S. from the organization are addressed. This implies that the WHO should apply pressure on China to identify the pandemic's origins. WHO Director-General Tedros Adhanom Ghebreyesus, for his part, has refused to accept the Chinese government's prevarications. If Trump can propose a way to determine the cause of COVID-19, I am sure that the WHO's leadership would gladly hear it. Trump's second condition is that the WHO undertake reforms and use its resources more effectively at the local level, with a greater focus on stopping the spread of infectious diseases. This is a demand that can and should be met. To that end, Tedros has already promised more targeted use of funds and implemented other measures to transform the organization. In addition, under Tedros, the WHO has transformed the way it raises funds. Its member states have sharply increased their annual contributions and it has diversified its donor base to share the funding load more widely. This is all part of the WHO's drive to be more sustainably financed, a plan launched as part of Tedros's effort to transform the organization's operations after he took office in 2017. Back then, he and member states assessed that the departure of a major donor could leave the WHO's programs and independence vulnerable to funding shocks. Who knew it would be the U.S. But, had those changes not been made, we can only imagine how much more challenging the WHO's current financial situation would be. The Trump administration should welcome these changes, not least because it benefits from having a seat at the table. If the U.S. ultimately abandons the WHO, developing evidence-based guidance and regulations for chronic-disease prevention and management will be significantly harder, undermining the administration's goal of addressing America's chronic-disease epidemic. The U.S. will also no longer be a part of the WHO's medicine prequalification process, a program that opens a host of new markets for drug producers in a cost-effective manner. Instead, U.S. pharmaceutical companies will be forced to sell their prequalified products to each country individually, putting them at risk of losing access to highly profitable multibillion dollar markets. Twenty-first-century trends — including more mobility and international travel, greater urbanization and increasing human encroachment on nature — fuel the global spread of infectious diseases, to the detriment of everyone. U.S. officials would be better positioned to protect their citizens if they joined — and perhaps even led — a discussion on how the WHO and other global health organizations, such as Gavi, the Vaccine Alliance and the Global Fund to Fight AIDS, Tuberculosis, and Malaria, can meet the world's needs. One such initiative, in which the U.S. had been a strong partner until Trump took office, was to negotiate a WHO Pandemic Agreement, which WHO member states adopted by consensus at the World Health Assembly on May 20. This historic compact, based on the principles of equity, collaboration and the reaffirmation of national sovereignty in public-health decision-making, will make the world safer from future pandemics. The U.S., bolstered by its world-class medical professionals and substantial public investment in medical research, has long exerted considerable influence on global health priorities. But withdrawing from the WHO places America on the outside, unable to shape the agency's policy agenda and reforms. When the next pandemic strikes, the U.S. will be left watching from the sidelines, as the WHO and its remaining member countries manage the global response and pick up the pieces as they see fit. Gordon Brown, a former prime minister of the United Kingdom, is U.N. Special Envoy for Global Education and Chair of Education Cannot Wait. © Project Syndicate, 2025.
Japan Today
25-05-2025
- Health
- Japan Today
Measles are very contagious. Here's how to avoid getting infected
By DEVI SHASTRI and LAURA UNGAR New Jersey health officials are asking people who went to Shakira concert on May 16 at MetLife Stadium to monitor for measles symptoms because a person went to see the singer while infectious. There is no confirmed outbreak in New Jersey, but the U.S. and North America are seeing high measles activity this year — including hundreds sickened by the highly infectious airborne virus in West Texas — and declining rates of people getting the vaccine, which is 97% effective after two doses. Schools and daycares are among the most common places for measles exposures, like one that happened in three western North Dakota public schools in early May that led to all unvaccinated students being held at home for 21 days under state law. Here's what to know about the measles and how to protect yourself. Most U.S. children get vaccinated against measles before entering public school, but increasing numbers of people skipping shots for religious or personal reasons have fueled outbreaks in the U.S. and abroad this year. Overall, the U.S. has seen more than 1,000 measles cases across 30 states since the beginning of the year, and 11 states with outbreaks — defined as three or more related cases. The largest outbreak in the U.S. has been in Texas, New Mexico and Oklahoma. There are also large outbreaks in Mexico and Canada. It's a respiratory disease caused by one of the world's most contagious viruses. The virus is airborne and spreads easily when an infected person breathes, sneezes or coughs. It most commonly affects kids. 'On average, one infected person may infect about 15 other people,' said Scott Weaver, a center of excellence director for the Global Virus Network, an international coalition. 'There's only a few viruses that even come close to that.' Measles first infects the respiratory tract, then spreads throughout the body, causing a high fever, runny nose, cough, red, watery eyes and a rash. The rash generally appears three to five days after the first symptoms, beginning as flat red spots on the face and then spreading downward to the neck, trunk, arms, legs and feet. When the rash appears, the fever may spike over 104 degrees Fahrenheit, according to the CDC. There's no specific treatment for measles, so doctors generally try to alleviate symptoms, prevent complications and keep patients comfortable. People who have had measles once can't get it again, health officials say. It usually doesn't kill people, but it can. Common complications include ear infections and diarrhea. But about 1 in 5 unvaccinated Americans who get measles are hospitalized, the CDC said. Pregnant women who haven't gotten the vaccine may give birth prematurely or have a low-birthweight baby. Among children with measles, about 1 in every 20 develops pneumonia, the CDC said, and about one in every 1,000 suffers swelling of the brain called encephalitis — which can lead to convulsions, deafness or intellectual disability. 'Children develop the most severe illness," said Weaver, who works at the University of Texas Medical Branch in Galveston. "The cause of death in these kinds of cases is usually pneumonia and complications from pneumonia.' The best way to avoid measles is to get the measles, mumps and rubella (MMR) vaccine. The first shot is recommended for children between 12 and 15 months old and the second between 4 and 6 years old. 'Before a vaccine was developed in the 1960s, everybody got' measles, Weaver said. There is 'great data' on the safety and effectiveness of the vaccine, he said, because it's been around for decades. 'Any of these outbreaks we're seeing can easily be prevented by increasing the rate of vaccination in the community,' he said. 'If we can maintain 95% of people vaccinated, we're not going to see this happening in the future. And we've slipped well below that level in many parts of the country.' Vaccination rates have declined nationwide since the COVID-19 pandemic, and most states are below the 95% vaccination threshold for kindergartners — the level needed to protect communities against measles outbreaks. Not usually. People who are vaccinated are considered protected against measles for their lifetime. Health care providers can test for antibodies and give boosters if needed. Getting another MMR shot as an adult is harmless if there are concerns about waning immunity, the CDC says. People who have documentation of receiving a live measles vaccine in the 1960s don't need to be revaccinated, but people who were immunized before 1968 with an ineffective vaccine made from 'killed' virus should be revaccinated with at least one dose, the agency said. People who have documentation that they had measles are immune, and those born before 1957 generally don't need the shots because so many children got measles back then that they have 'presumptive immunity.' Weaver said people at high risk for infection who got the shots many years ago may want to consider getting a booster if they live in an area with an outbreak. Those may include family members living with someone who has measles or those especially vulnerable to respiratory diseases because of underlying medical conditions. © Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
